Predictive hyperglycemia and hypoglycemia minimization: In-home evaluation of safety, feasibility, and efficacy in overnight glucose control in type 1 diabetes

Diabetes Care

Volumn 40, Issue 3, 2017, Pages 359-366

  Spaic, Tamara ^a   Driscoll, Marsha ^a   Raghinaru, Dan ^b   Buckingham, Bruce A ^c   Wilson, Darrell M ^c   Clinton, Paula ^c   Chase, H Peter ^d   Maahs, David M ^c,d   Forlenza, Gregory P ^d   Jost, Emily ^d   Hramiak, Irene ^a   Paul, Terri ^a   Bequette, B Wayne ^e   Cameron, Faye ^e   Beck, Roy W ^b   Kollman, Craig ^b   Lum, John W ^b   Trang, T Ly ^c  

^a ST JOSEPH S HEALTH CENTRE   (Canada)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; KETONE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; BLOOD GLUCOSE MONITORING; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PREDICTIVE HYPERGLYCEMIA AND HYPOGLYCEMIA MINIMIZATION; PREDICTIVE LOW GLUCOSE INSULIN SUSPENSION; RANDOMIZED CONTROLLED TRIAL; SAFETY; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; DOUBLE BLIND PROCEDURE; INSULIN INFUSION; METABOLISM; MULTICENTER STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DOUBLE-BLIND METHOD; FEASIBILITY STUDIES; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; YOUNG ADULT;

EID: 85018656773     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-1794     Document Type: Article

References (35)

1. Elleri D, Allen JM, Kumareswaran K, et al. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care 2013;36:838-844
2. Hovorka R, Kumareswaran K, Harris J, et al. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ 2011; 342:d1855
3. Kovatchev BP, Renard E, Cobelli C, et al. Feasibility of outpatient fully integrated closedloop control: first studies of wearable artificial pancreas. Diabetes Care 2013;36:1851-1858
4. Luijf YM, DeVries JH, Zwinderman K, et al.; AP@home Consortium. Day and night closedloop control in adultswith type 1 diabetes: A comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management. Diabetes Care 2013; 36:3882-3887
5. OGrady MJ, Retterath AJ, Keenan DB, et al. The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes. Diabetes Care 2012;35:2182-2187
6. Brown SA, Kovatchev BP, Breton MD, et al. Multinight "bedside" closed-loop control for patients with type 1 diabetes. Diabetes Technol Ther 2015;17:203-209
7. Haidar A, Legault L, Matteau-Pelletier L, et al. Outpatient overnight glucose control with dualhormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pumptherapy in children and adolescents with type 1 diabetes: An open-label, randomised controlled trial. Lancet Diabetes Endocrinol 2015;3:595-604
8. Kovatchev BP, Renard E, Cobelli C, et al. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas. Diabetes Care 2014;37:1789-1796
9. Leelarathna L, Dellweg S, Mader JK, et al.; AP@home Consortium. Day and night home closed-loop insulin delivery in adults with type 1 diabetes: Three-center randomized crossover study. Diabetes Care 2014;37:1931-1937
10. Ly TT, Roy A, Grosman B, et al. Day and night closed-loop control using the integrated medtronic hybrid closed-loop system in type 1 diabetes at diabetes camp. Diabetes Care 2015; 38:1205-1211
11. Phillip M, Battelino T, Atlas E, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013;368: 824-833
12. Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014;371:313-325
13. Russell SJ, Hillard MA, Balliro C, et al. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: A randomised crossover trial. Lancet Diabetes Endocrinol 2016;4:233-243
14. Thabit H, Tauschmann M, Allen JM, et al.; APCam Consortium; AP@home Consortium. Home use of an artificial beta cell in type 1 diabetes. N Engl J Med 2015;373:2129-2140
15. Buckingham B, Wilson DM, Lecher T, Hanas R, Kaiserman K, Cameron F. Duration of nocturnal hypoglycemia before seizures. Diabetes Care 2008;31:2110-2112
16. Tanenberg RJ, Newton CA, Drake AJ. Confirmation of hypoglycemia in the "dead-in-bed" syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract 2010;16:244-248
17. Jones T, Porter P, David E, et al. Suppressed epinephrine responses during sleep. N Engl J Med 1998;338:1657-1662
18. Ly TT, Jones TW, Griffiths A, et al. Hypoglycemia does not change the threshold for arousal from sleep in adolescents with type 1 diabetes. Diabetes Technol Ther 2012;14:101-104
19. Buckingham B, Block J, Burdick J, et al.; Diabetes Research in Children Network. Response to nocturnal alarms using a real-Time glucose sensor. Diabetes Technol Ther 2005;7:440-447
20. Anderson SM, Raghinaru D, Pinsker JE, et al.; Control to Range Study Group. Multinational home use of closed-loop control is safe and effective. Diabetes Care 2016;39:1143-1150
21. Ly TT, Buckingham BA, DeSalvo DJ, et al. Day-And-night closed-loop control using the unified safety system in adolescents with type 1 diabetes at camp. Diabetes Care 2016; 39:e106-e107
22. Buckingham BA, Raghinaru D, Cameron F, et al.; In Home Closed Loop Study Group. Predictive low-glucose insulin suspension reduces duration of nocturnal hypoglycemia in children without increasing ketosis. Diabetes Care 2015; 38:1197-1204
23. Maahs DM, Calhoun P, Buckingham BA, et al.; In Home Closed Loop Study Group. A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes. Diabetes Care 2014;37:1885-1891
24. Buckingham BA, Cameron F, Calhoun P, et al. Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia. Diabetes Technol Ther 2013;15:622-627
25. Cameron F, Wilson DM, Buckingham BA, et al. Inpatient studies of a Kalman-filter-based predictive pump shutoff algorithm. J Diabetes Sci Technol 2012;6:1142-1147
26. The DCCT Research Group. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. Diabetes 1986;35:530-545
27. International Organization for Standardization. ISO 15197:2013: in vitro diagnostic test systemsdrequirements for blood-glucose monitoring systems for self-Testing in managing diabetes mellitus. Geneva, Switzerland, International Organization for Standardization, 2013
28. Ly TT, Keenan DB, Roy A, et al. Automated overnight closed-loop control using a proportional-integral-derivative algorithm with insulin feedback in children and adolescents with type 1 diabetes at diabetes camp. Diabetes Technol Ther 2016;18:377-384
29. Hovorka R, Elleri D, Thabit H, et al. Overnight closed-loop insulin delivery in young people with type 1 diabetes: A free-living, randomized clinical trial. Diabetes Care 2014;37: 1204-1211
30. Pinsker JE, Lee JB, Dassau E, et al. Randomized crossover comparison of personalized MPC and PID control algorithms for the artificial pancreas. Diabetes Care 2016;39:1135-1142
31. Kropff J, Del Favero S, Place J, et al.; AP@home consortium. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial. Lancet Diabetes Endocrinol 2015;3:939-947
32. Ly TT, Breton MD, Keith-Hynes P, et al. Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp. Diabetes Care 2014;37:2310-2316
33. Nimri R, Muller I, Atlas E, et al. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial. Diabetes Care 2014;37:3025-3032
34. Thabit H, Lubina-Solomon A, Stadler M, et al. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: A 4-week, multicentre, randomised crossover study. Lancet Diabetes Endocrinol 2014;2:701-709
35. Barnard KD, Wysocki T, Allen JM, et al. Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents. BMJ Open Diabetes Res Care 2014;2:e000025